メタ情報
| meta description平均長 | 0 |
|---|
| OGPありページ数 | 14 |
|---|
| Twitterカードありページ数 | 14 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 12 |
|---|
| ページあたり内部リンク平均 | 13.64 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| your | 1 |
| information | 1 |
| Website | 0.925926 |
| you | 0.637011 |
| End | 0.477184 |
| Information | 0.444444 |
| our | 0.395816 |
| request | 0.376724 |
| time | 0.326494 |
| cookies | 0.326494 |
| Policy | 0.296296 |
| User | 0.276264 |
| Personal | 0.276264 |
| data | 0.251149 |
| will | 0.249218 |
| Privacy | 0.240741 |
| third | 0.226035 |
| provide | 0.20092 |
| example | 0.20092 |
| used | 0.20092 |
| Usage | 0.20092 |
| Data | 0.20092 |
| Users | 0.20092 |
| access | 0.175918 |
| Agreement | 0.175805 |
| Please | 0.161258 |
| com | 0.15069 |
| make | 0.15069 |
| user | 0.15069 |
| websites | 0.15069 |
| party | 0.15069 |
| security | 0.15069 |
| Non | 0.15069 |
| Identifying | 0.15069 |
| device | 0.15069 |
| identity | 0.15069 |
| verify | 0.15069 |
| business | 0.146599 |
| Email | 0.12963 |
| team | 0.125575 |
| experience | 0.125575 |
| Paul | 0.125575 |
| acrotech | 0.125575 |
| medinfodept | 0.125575 |
| Oncology | 0.125575 |
| privacy | 0.125575 |
| certain | 0.125575 |
| does | 0.125575 |
| visit | 0.125575 |
| policies | 0.125575 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| CSF | rhG | 5.471135 | 616 |
| abdominal | pain | 4.977562 | 364 |
| AML | MDS | 4.912234 | 350 |
| CSF | products | 4.777252 | 616 |
| arm | control | 4.634022 | 252 |
| anti | myeloma | 4.628621 | 224 |
| regimen | therapeutic | 4.564413 | 280 |
| been | has | 4.539207 | 396 |
| infection | tract | 4.41017 | 238 |
| malignancies | secondary | 4.366128 | 224 |
| negative | side | 4.358297 | 116 |
| drugs | prescription | 4.358297 | 116 |
| fda | www | 4.358297 | 116 |
| fda | gov | 4.358297 | 116 |
| gov | medwatch | 4.358297 | 116 |
| infarction | myocardial | 4.329117 | 112 |
| contraception | effective | 4.329117 | 112 |
| cutaneous | mucocutaneous | 4.329117 | 112 |
| refractory | relapsed | 4.329117 | 112 |
| NHL | refractory | 4.329117 | 112 |
| primary | second | 4.329117 | 112 |
| malignancy | primary | 4.329117 | 112 |
| asthenia | cough | 4.329117 | 112 |
| Acrotech | Biopharma | 4.324711 | 229 |
| Visit | www | 4.297802 | 112 |
| Refer | prescribing | 4.267547 | 112 |
| adverse | reactions | 4.252426 | 504 |
| containing | fludarabine | 4.244062 | 112 |
| can | occur | 4.180109 | 336 |
| granulocyte | stimulating | 4.157875 | 140 |
| prolonged | severe | 4.154415 | 266 |
| Policy | Privacy | 4.137786 | 100 |
| call | medwatch | 4.124535 | 112 |
| first | line | 4.11134 | 168 |
| counts | platelet | 4.097381 | 126 |
| respiratory | tract | 4.035134 | 182 |
| Alterations | Function | 4.028847 | 112 |
| fetal | harm | 4.028847 | 112 |
| Kaposi | Sarcoma | 4.013991 | 70 |
| effects | side | 4.001826 | 116 |
| effects | prescription | 4.001826 | 116 |
| filgrastim | pegfilgrastim | 3.991546 | 98 |
| breast | cancer | 3.991546 | 98 |
| dose | reduction | 3.982312 | 182 |
| colony | granulocyte | 3.967277 | 112 |
| colony | stimulating | 3.967277 | 112 |
| follow | median | 3.967277 | 112 |
| Deaths | due | 3.967277 | 112 |
| fatigue | nasopharyngitis | 3.967277 | 112 |
| nasopharyngitis | nausea | 3.967277 | 112 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録